Multiple researchers from academic medical institutions across Italy analyzed HealthMyne's radiomic and quantitative imaging solution for use in lung carcinoma. The study demonstrated HealthMyne's quantitative volumetric delineation was consistent and that several radiomic metrics extracted by the tool were significant and robust predictors of RECIST response.
Intrigued? Let's talk and find out what's important to you
Once we understand your needs we can customize a demo specifically for you and your team